FLIPI Score & Lymphoma: The Five Factors

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate survival rates based on certain factors. The relationship of FLIPI score and lymphoma has been the subject of debate, but it is largely valued as a tool.

Using data collected from 4167 patients from 1985 to 1992, an international panel derived and validated an index based on five diagnostic factors (see below). This was an outgrowth of the more general International Prognostic Index (IPI) for intermediate grade lymphomas. The FLIPI score applies specifically to follicular lymphoma (FL), the most common low-grade form of the cancer. It is especially helpful because FL, while slow-growing, is notoriously difficult to treat. It is therefore necessary to have a quantifiable measure of survivability.

The five factors which are taken into account when computing the FLIPI are:

1. Over 60 years of age

2. Disease at stage III or IV

3. Five or more nodules or tumors detected, or more than four lymph node groups involved

4. Serum hemoglobin less than 12 g/dL

5. Elevated serum LDH

Each of these factors is assigned one point if positive, the points are totaled to give the final FLIPI score and lymphoma prognoses are based on this score. The following are the three levels of risk into which the FLIPI score can place a person:

0-1 points/Low risk. At this level, a person can expect a 91 percent survival rate at 5 years from diagnosis and 71 percent at ten years.

2 points/Intermediate risk. The five-year survival rate is 78 percent and the ten years is 51 percent.

3-5 points/High risk. At the worst level, five and ten-year survival rates drop to 53 percent and 36 percent, respectively.

The relationship between FLIPI score and lymphoma survival rates is often misunderstood, however. Too often, a "five year survival rate" is taken to mean that the patient is likely to live only five years. There are two major errors in this reasoning. First, the five-year rate can easily include data from patients who went on to live for six, twelve, or even thirty more years. Secondly, with most diseases, survival expectations rise for each year you live after the initial diagnosis. So, for example, the five-year survival rate might be 78 percent at diagnosis, but if you are still alive after a year, that rate might increase to 85 percent.

It's important to understand what FLIPI is, how it can be used, and how it is computed, but also keep in mind that it is only one of many tools that you and your doctor can use to design effective courses of treatment.

Photo: Pexels

More Articles

More Articles

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...

Secondary cancers are cancers that develop as a result of chemotherapy and/or...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...

Over the years, various classification systems have been used to differentiate lymphoma types including the Rappaport Classification (used until...

If you are new to this website or are looking for guidance to a specific page, here is a list of links to articles that can help you. The "Main...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...